0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Coronary Drug-Eluting Stent Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-14H16897
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Medical Coronary Drug Eluting Stent Market Research Report 2024
BUY CHAPTERS

Global Medical Coronary Drug-Eluting Stent Market Research Report 2025

Code: QYRE-Auto-14H16897
Report
September 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medical Coronary Drug-Eluting Stent Market

The global market for Medical Coronary Drug-Eluting Stent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Medical Coronary Drug-Eluting Stent is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Medical Coronary Drug-Eluting Stent is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Medical Coronary Drug-Eluting Stent include Medtronic, Boston Scientific, Abbott, B.Braun, Biosensors International, MicroPort, Lepu Medical, Terumo, Blue Sail Medical, SINOMED, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medical Coronary Drug-Eluting Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Coronary Drug-Eluting Stent.
The Medical Coronary Drug-Eluting Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medical Coronary Drug-Eluting Stent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Coronary Drug-Eluting Stent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Medical Coronary Drug-Eluting Stent Market Report

Report Metric Details
Report Name Medical Coronary Drug-Eluting Stent Market
Segment by Type
  • Polymer Stent
  • Polymer-Free Stent
  • Others
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, Boston Scientific, Abbott, B.Braun, Biosensors International, MicroPort, Lepu Medical, Terumo, Blue Sail Medical, SINOMED, Liaoning Yinyi Biological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Medical Coronary Drug-Eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Medical Coronary Drug-Eluting Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Medical Coronary Drug-Eluting Stent Market report?

Ans: The main players in the Medical Coronary Drug-Eluting Stent Market are Medtronic, Boston Scientific, Abbott, B.Braun, Biosensors International, MicroPort, Lepu Medical, Terumo, Blue Sail Medical, SINOMED, Liaoning Yinyi Biological

What are the Application segmentation covered in the Medical Coronary Drug-Eluting Stent Market report?

Ans: The Applications covered in the Medical Coronary Drug-Eluting Stent Market report are Hospital, Clinic

What are the Type segmentation covered in the Medical Coronary Drug-Eluting Stent Market report?

Ans: The Types covered in the Medical Coronary Drug-Eluting Stent Market report are Polymer Stent, Polymer-Free Stent, Others

1 Medical Coronary Drug-Eluting Stent Market Overview
1.1 Product Definition
1.2 Medical Coronary Drug-Eluting Stent by Type
1.2.1 Global Medical Coronary Drug-Eluting Stent Market Value Comparison by Type (2024 VS 2031)
1.2.2 Polymer Stent
1.2.3 Polymer-Free Stent
1.2.4 Others
1.3 Medical Coronary Drug-Eluting Stent by Application
1.3.1 Global Medical Coronary Drug-Eluting Stent Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Medical Coronary Drug-Eluting Stent Market Size Estimates and Forecasts
1.4.1 Global Medical Coronary Drug-Eluting Stent Revenue 2020-2031
1.4.2 Global Medical Coronary Drug-Eluting Stent Sales 2020-2031
1.4.3 Global Medical Coronary Drug-Eluting Stent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Medical Coronary Drug-Eluting Stent Market Competition by Manufacturers
2.1 Global Medical Coronary Drug-Eluting Stent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Medical Coronary Drug-Eluting Stent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Medical Coronary Drug-Eluting Stent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Medical Coronary Drug-Eluting Stent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medical Coronary Drug-Eluting Stent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Coronary Drug-Eluting Stent, Product Type & Application
2.7 Global Key Manufacturers of Medical Coronary Drug-Eluting Stent, Date of Enter into This Industry
2.8 Global Medical Coronary Drug-Eluting Stent Market Competitive Situation and Trends
2.8.1 Global Medical Coronary Drug-Eluting Stent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Medical Coronary Drug-Eluting Stent Players Market Share by Revenue
2.8.3 Global Medical Coronary Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Medical Coronary Drug-Eluting Stent Market Scenario by Region
3.1 Global Medical Coronary Drug-Eluting Stent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Medical Coronary Drug-Eluting Stent Sales by Region: 2020-2031
3.2.1 Global Medical Coronary Drug-Eluting Stent Sales by Region: 2020-2025
3.2.2 Global Medical Coronary Drug-Eluting Stent Sales by Region: 2026-2031
3.3 Global Medical Coronary Drug-Eluting Stent Revenue by Region: 2020-2031
3.3.1 Global Medical Coronary Drug-Eluting Stent Revenue by Region: 2020-2025
3.3.2 Global Medical Coronary Drug-Eluting Stent Revenue by Region: 2026-2031
3.4 North America Medical Coronary Drug-Eluting Stent Market Facts & Figures by Country
3.4.1 North America Medical Coronary Drug-Eluting Stent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Medical Coronary Drug-Eluting Stent Sales by Country (2020-2031)
3.4.3 North America Medical Coronary Drug-Eluting Stent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Coronary Drug-Eluting Stent Market Facts & Figures by Country
3.5.1 Europe Medical Coronary Drug-Eluting Stent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Medical Coronary Drug-Eluting Stent Sales by Country (2020-2031)
3.5.3 Europe Medical Coronary Drug-Eluting Stent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Coronary Drug-Eluting Stent Market Facts & Figures by Region
3.6.1 Asia Pacific Medical Coronary Drug-Eluting Stent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Medical Coronary Drug-Eluting Stent Sales by Region (2020-2031)
3.6.3 Asia Pacific Medical Coronary Drug-Eluting Stent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Medical Coronary Drug-Eluting Stent Market Facts & Figures by Country
3.7.1 Latin America Medical Coronary Drug-Eluting Stent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Medical Coronary Drug-Eluting Stent Sales by Country (2020-2031)
3.7.3 Latin America Medical Coronary Drug-Eluting Stent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Coronary Drug-Eluting Stent Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Coronary Drug-Eluting Stent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Medical Coronary Drug-Eluting Stent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Medical Coronary Drug-Eluting Stent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Coronary Drug-Eluting Stent Sales by Type (2020-2031)
4.1.1 Global Medical Coronary Drug-Eluting Stent Sales by Type (2020-2025)
4.1.2 Global Medical Coronary Drug-Eluting Stent Sales by Type (2026-2031)
4.1.3 Global Medical Coronary Drug-Eluting Stent Sales Market Share by Type (2020-2031)
4.2 Global Medical Coronary Drug-Eluting Stent Revenue by Type (2020-2031)
4.2.1 Global Medical Coronary Drug-Eluting Stent Revenue by Type (2020-2025)
4.2.2 Global Medical Coronary Drug-Eluting Stent Revenue by Type (2026-2031)
4.2.3 Global Medical Coronary Drug-Eluting Stent Revenue Market Share by Type (2020-2031)
4.3 Global Medical Coronary Drug-Eluting Stent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Medical Coronary Drug-Eluting Stent Sales by Application (2020-2031)
5.1.1 Global Medical Coronary Drug-Eluting Stent Sales by Application (2020-2025)
5.1.2 Global Medical Coronary Drug-Eluting Stent Sales by Application (2026-2031)
5.1.3 Global Medical Coronary Drug-Eluting Stent Sales Market Share by Application (2020-2031)
5.2 Global Medical Coronary Drug-Eluting Stent Revenue by Application (2020-2031)
5.2.1 Global Medical Coronary Drug-Eluting Stent Revenue by Application (2020-2025)
5.2.2 Global Medical Coronary Drug-Eluting Stent Revenue by Application (2026-2031)
5.2.3 Global Medical Coronary Drug-Eluting Stent Revenue Market Share by Application (2020-2031)
5.3 Global Medical Coronary Drug-Eluting Stent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Medical Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Medtronic Medical Coronary Drug-Eluting Stent Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Medical Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific Medical Coronary Drug-Eluting Stent Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Company Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Medical Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Medical Coronary Drug-Eluting Stent Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 B.Braun
6.4.1 B.Braun Company Information
6.4.2 B.Braun Description and Business Overview
6.4.3 B.Braun Medical Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 B.Braun Medical Coronary Drug-Eluting Stent Product Portfolio
6.4.5 B.Braun Recent Developments/Updates
6.5 Biosensors International
6.5.1 Biosensors International Company Information
6.5.2 Biosensors International Description and Business Overview
6.5.3 Biosensors International Medical Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biosensors International Medical Coronary Drug-Eluting Stent Product Portfolio
6.5.5 Biosensors International Recent Developments/Updates
6.6 MicroPort
6.6.1 MicroPort Company Information
6.6.2 MicroPort Description and Business Overview
6.6.3 MicroPort Medical Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 MicroPort Medical Coronary Drug-Eluting Stent Product Portfolio
6.6.5 MicroPort Recent Developments/Updates
6.7 Lepu Medical
6.7.1 Lepu Medical Company Information
6.7.2 Lepu Medical Description and Business Overview
6.7.3 Lepu Medical Medical Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lepu Medical Medical Coronary Drug-Eluting Stent Product Portfolio
6.7.5 Lepu Medical Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Company Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Medical Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Terumo Medical Coronary Drug-Eluting Stent Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 Blue Sail Medical
6.9.1 Blue Sail Medical Company Information
6.9.2 Blue Sail Medical Description and Business Overview
6.9.3 Blue Sail Medical Medical Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Blue Sail Medical Medical Coronary Drug-Eluting Stent Product Portfolio
6.9.5 Blue Sail Medical Recent Developments/Updates
6.10 SINOMED
6.10.1 SINOMED Company Information
6.10.2 SINOMED Description and Business Overview
6.10.3 SINOMED Medical Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SINOMED Medical Coronary Drug-Eluting Stent Product Portfolio
6.10.5 SINOMED Recent Developments/Updates
6.11 Liaoning Yinyi Biological
6.11.1 Liaoning Yinyi Biological Company Information
6.11.2 Liaoning Yinyi Biological Description and Business Overview
6.11.3 Liaoning Yinyi Biological Medical Coronary Drug-Eluting Stent Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Liaoning Yinyi Biological Medical Coronary Drug-Eluting Stent Product Portfolio
6.11.5 Liaoning Yinyi Biological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Coronary Drug-Eluting Stent Industry Chain Analysis
7.2 Medical Coronary Drug-Eluting Stent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Coronary Drug-Eluting Stent Production Mode & Process Analysis
7.4 Medical Coronary Drug-Eluting Stent Sales and Marketing
7.4.1 Medical Coronary Drug-Eluting Stent Sales Channels
7.4.2 Medical Coronary Drug-Eluting Stent Distributors
7.5 Medical Coronary Drug-Eluting Stent Customer Analysis
8 Medical Coronary Drug-Eluting Stent Market Dynamics
8.1 Medical Coronary Drug-Eluting Stent Industry Trends
8.2 Medical Coronary Drug-Eluting Stent Market Drivers
8.3 Medical Coronary Drug-Eluting Stent Market Challenges
8.4 Medical Coronary Drug-Eluting Stent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Medical Coronary Drug-Eluting Stent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Medical Coronary Drug-Eluting Stent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Medical Coronary Drug-Eluting Stent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Medical Coronary Drug-Eluting Stent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Medical Coronary Drug-Eluting Stent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Medical Coronary Drug-Eluting Stent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Medical Coronary Drug-Eluting Stent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Medical Coronary Drug-Eluting Stent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Medical Coronary Drug-Eluting Stent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Medical Coronary Drug-Eluting Stent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Medical Coronary Drug-Eluting Stent, Product Type & Application
 Table 12. Global Key Manufacturers of Medical Coronary Drug-Eluting Stent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Medical Coronary Drug-Eluting Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Coronary Drug-Eluting Stent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Medical Coronary Drug-Eluting Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Medical Coronary Drug-Eluting Stent Sales by Region (2020-2025) & (K Units)
 Table 18. Global Medical Coronary Drug-Eluting Stent Sales Market Share by Region (2020-2025)
 Table 19. Global Medical Coronary Drug-Eluting Stent Sales by Region (2026-2031) & (K Units)
 Table 20. Global Medical Coronary Drug-Eluting Stent Sales Market Share by Region (2026-2031)
 Table 21. Global Medical Coronary Drug-Eluting Stent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Medical Coronary Drug-Eluting Stent Revenue Market Share by Region (2020-2025)
 Table 23. Global Medical Coronary Drug-Eluting Stent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Medical Coronary Drug-Eluting Stent Revenue Market Share by Region (2026-2031)
 Table 25. North America Medical Coronary Drug-Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Medical Coronary Drug-Eluting Stent Sales by Country (2020-2025) & (K Units)
 Table 27. North America Medical Coronary Drug-Eluting Stent Sales by Country (2026-2031) & (K Units)
 Table 28. North America Medical Coronary Drug-Eluting Stent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Medical Coronary Drug-Eluting Stent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Medical Coronary Drug-Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Medical Coronary Drug-Eluting Stent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Medical Coronary Drug-Eluting Stent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Medical Coronary Drug-Eluting Stent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Medical Coronary Drug-Eluting Stent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Medical Coronary Drug-Eluting Stent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Medical Coronary Drug-Eluting Stent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Medical Coronary Drug-Eluting Stent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Medical Coronary Drug-Eluting Stent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Medical Coronary Drug-Eluting Stent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Medical Coronary Drug-Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Medical Coronary Drug-Eluting Stent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Medical Coronary Drug-Eluting Stent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Medical Coronary Drug-Eluting Stent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Medical Coronary Drug-Eluting Stent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Medical Coronary Drug-Eluting Stent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Medical Coronary Drug-Eluting Stent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Medical Coronary Drug-Eluting Stent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Medical Coronary Drug-Eluting Stent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Medical Coronary Drug-Eluting Stent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Medical Coronary Drug-Eluting Stent Sales (K Units) by Type (2020-2025)
 Table 51. Global Medical Coronary Drug-Eluting Stent Sales (K Units) by Type (2026-2031)
 Table 52. Global Medical Coronary Drug-Eluting Stent Sales Market Share by Type (2020-2025)
 Table 53. Global Medical Coronary Drug-Eluting Stent Sales Market Share by Type (2026-2031)
 Table 54. Global Medical Coronary Drug-Eluting Stent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Medical Coronary Drug-Eluting Stent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Medical Coronary Drug-Eluting Stent Revenue Market Share by Type (2020-2025)
 Table 57. Global Medical Coronary Drug-Eluting Stent Revenue Market Share by Type (2026-2031)
 Table 58. Global Medical Coronary Drug-Eluting Stent Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Medical Coronary Drug-Eluting Stent Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Medical Coronary Drug-Eluting Stent Sales (K Units) by Application (2020-2025)
 Table 61. Global Medical Coronary Drug-Eluting Stent Sales (K Units) by Application (2026-2031)
 Table 62. Global Medical Coronary Drug-Eluting Stent Sales Market Share by Application (2020-2025)
 Table 63. Global Medical Coronary Drug-Eluting Stent Sales Market Share by Application (2026-2031)
 Table 64. Global Medical Coronary Drug-Eluting Stent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Medical Coronary Drug-Eluting Stent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Medical Coronary Drug-Eluting Stent Revenue Market Share by Application (2020-2025)
 Table 67. Global Medical Coronary Drug-Eluting Stent Revenue Market Share by Application (2026-2031)
 Table 68. Global Medical Coronary Drug-Eluting Stent Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Medical Coronary Drug-Eluting Stent Price (US$/Unit) by Application (2026-2031)
 Table 70. Medtronic Company Information
 Table 71. Medtronic Description and Business Overview
 Table 72. Medtronic Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Medtronic Medical Coronary Drug-Eluting Stent Product
 Table 74. Medtronic Recent Developments/Updates
 Table 75. Boston Scientific Company Information
 Table 76. Boston Scientific Description and Business Overview
 Table 77. Boston Scientific Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boston Scientific Medical Coronary Drug-Eluting Stent Product
 Table 79. Boston Scientific Recent Developments/Updates
 Table 80. Abbott Company Information
 Table 81. Abbott Description and Business Overview
 Table 82. Abbott Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Abbott Medical Coronary Drug-Eluting Stent Product
 Table 84. Abbott Recent Developments/Updates
 Table 85. B.Braun Company Information
 Table 86. B.Braun Description and Business Overview
 Table 87. B.Braun Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. B.Braun Medical Coronary Drug-Eluting Stent Product
 Table 89. B.Braun Recent Developments/Updates
 Table 90. Biosensors International Company Information
 Table 91. Biosensors International Description and Business Overview
 Table 92. Biosensors International Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Biosensors International Medical Coronary Drug-Eluting Stent Product
 Table 94. Biosensors International Recent Developments/Updates
 Table 95. MicroPort Company Information
 Table 96. MicroPort Description and Business Overview
 Table 97. MicroPort Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. MicroPort Medical Coronary Drug-Eluting Stent Product
 Table 99. MicroPort Recent Developments/Updates
 Table 100. Lepu Medical Company Information
 Table 101. Lepu Medical Description and Business Overview
 Table 102. Lepu Medical Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Lepu Medical Medical Coronary Drug-Eluting Stent Product
 Table 104. Lepu Medical Recent Developments/Updates
 Table 105. Terumo Company Information
 Table 106. Terumo Description and Business Overview
 Table 107. Terumo Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Terumo Medical Coronary Drug-Eluting Stent Product
 Table 109. Terumo Recent Developments/Updates
 Table 110. Blue Sail Medical Company Information
 Table 111. Blue Sail Medical Description and Business Overview
 Table 112. Blue Sail Medical Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Blue Sail Medical Medical Coronary Drug-Eluting Stent Product
 Table 114. Blue Sail Medical Recent Developments/Updates
 Table 115. SINOMED Company Information
 Table 116. SINOMED Description and Business Overview
 Table 117. SINOMED Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. SINOMED Medical Coronary Drug-Eluting Stent Product
 Table 119. SINOMED Recent Developments/Updates
 Table 120. Liaoning Yinyi Biological Company Information
 Table 121. Liaoning Yinyi Biological Description and Business Overview
 Table 122. Liaoning Yinyi Biological Medical Coronary Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Liaoning Yinyi Biological Medical Coronary Drug-Eluting Stent Product
 Table 124. Liaoning Yinyi Biological Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Medical Coronary Drug-Eluting Stent Distributors List
 Table 128. Medical Coronary Drug-Eluting Stent Customers List
 Table 129. Medical Coronary Drug-Eluting Stent Market Trends
 Table 130. Medical Coronary Drug-Eluting Stent Market Drivers
 Table 131. Medical Coronary Drug-Eluting Stent Market Challenges
 Table 132. Medical Coronary Drug-Eluting Stent Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Medical Coronary Drug-Eluting Stent
 Figure 2. Global Medical Coronary Drug-Eluting Stent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Medical Coronary Drug-Eluting Stent Market Share by Type: 2024 & 2031
 Figure 4. Polymer Stent Product Picture
 Figure 5. Polymer-Free Stent Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Medical Coronary Drug-Eluting Stent Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Medical Coronary Drug-Eluting Stent Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Global Medical Coronary Drug-Eluting Stent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Medical Coronary Drug-Eluting Stent Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Medical Coronary Drug-Eluting Stent Sales (2020-2031) & (K Units)
 Figure 14. Global Medical Coronary Drug-Eluting Stent Average Price (US$/Unit) & (2020-2031)
 Figure 15. Medical Coronary Drug-Eluting Stent Report Years Considered
 Figure 16. Medical Coronary Drug-Eluting Stent Sales Share by Manufacturers in 2024
 Figure 17. Global Medical Coronary Drug-Eluting Stent Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Medical Coronary Drug-Eluting Stent Players: Market Share by Revenue in Medical Coronary Drug-Eluting Stent in 2024
 Figure 19. Medical Coronary Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Medical Coronary Drug-Eluting Stent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Medical Coronary Drug-Eluting Stent Sales Market Share by Country (2020-2031)
 Figure 22. North America Medical Coronary Drug-Eluting Stent Revenue Market Share by Country (2020-2031)
 Figure 23. United States Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Medical Coronary Drug-Eluting Stent Sales Market Share by Country (2020-2031)
 Figure 26. Europe Medical Coronary Drug-Eluting Stent Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Medical Coronary Drug-Eluting Stent Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Medical Coronary Drug-Eluting Stent Revenue Market Share by Region (2020-2031)
 Figure 34. China Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Medical Coronary Drug-Eluting Stent Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Medical Coronary Drug-Eluting Stent Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Medical Coronary Drug-Eluting Stent Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Medical Coronary Drug-Eluting Stent Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Medical Coronary Drug-Eluting Stent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Medical Coronary Drug-Eluting Stent by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Medical Coronary Drug-Eluting Stent by Type (2020-2031)
 Figure 53. Global Medical Coronary Drug-Eluting Stent Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Medical Coronary Drug-Eluting Stent by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Medical Coronary Drug-Eluting Stent by Application (2020-2031)
 Figure 56. Global Medical Coronary Drug-Eluting Stent Price (US$/Unit) by Application (2020-2031)
 Figure 57. Medical Coronary Drug-Eluting Stent Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Adult Artificial Heart Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32W16534
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Cardioplegia Adapter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33A16598
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Inotropic Drug Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23Y16200
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Retrograde Cardioplegia Cannula Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29Z16493
Thu Sep 25 00:00:00 UTC 2025

Add to Cart